Global private equity and venture capital news and research

Posts Tagged ‘Technology Partners’

17 April 2014

H.I.G. BioVentures leads $15m VC round for ForSight VISION5

ForSight VISION5 has closed a $15m Series C round led by H.I.G. BioVentures, alongside returning investors Morgenthaler Ventures, Versant Ventures, Technology Partners, and Delphi Ventures.

3 January 2014

Venture capital-backed Revance eyes Nasdaq IPO

stock brokerage market share listed Venture capital-backed biopharmaceutical company Revance Therapeutics is looking to raise $86.25m via an IPO on the Nasdaq exchange.

29 April 2013

Clinical-stage pharmaceutical company Scioderm adds $16m Series A

Clinical-stage pharmaceutical company Scioderm has completed a Series A financing round totaling $16m.

15 February 2013

Elcelyx Therapeutics scores $20m from returning VC backers

diabetes_lrg Elcelyx Therapeutics’ existing investors have supported the weight management specialist’s $20m Series C fundraising, which brought the total funds raised since its inception in 2010 to $43m.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016